Detail akcie TransMedics Grp Rg online

Business Summary: TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Financial Summary: BRIEF: For the 13 weeks ended 31 March 2025, TransMedics Group Inc revenues increased 48% to $143.5M. Net income increased from $12.2M to $25.7M. Revenues reflect OCS Liver net revenue segment increase of 63% to $108.9M, OCS Heart net revenue segment increase of 28% to $29.8M, United States segment increase of 51% to $138.6M. Net income benefited from Foreign Exchange Gain/LossNon-Business increase from $30K (expense) to $500.4M (income).